Company Arch Therapeutics, Inc.
Equities
ARTH
US03939W2089
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.96 USD | +18.52% |
|
+12.94% | -86.74% |
Jun. 12 | Arch Therapeutics, Inc. announced that it has received $0.15 million in funding | CI |
May. 15 | Arch Therapeutics, Inc. announced that it has received $1.85 million in funding | CI |
Business Summary
Number of employees: 8
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biotechnology
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +383.80% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +383.80% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Terrence Norchi
CEO | Chief Executive Officer | 59 | 09-09-15 |
Michael Abrams
DFI | Director of Finance/CFO | 55 | 21-05-09 |
Shawn Carlson
SAM | Sales & Marketing | - | 20-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Terrence Norchi
CEO | Chief Executive Officer | 59 | 09-09-15 |
Fish Guy
BRD | Director/Board Member | 64 | 21-12-30 |
Laurence Hicks
BRD | Director/Board Member | - | 21-09-26 |
Punit Dhillon
BRD | Director/Board Member | 44 | 18-06-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,444,363 | 4,288,423 ( 96.49 %) | 0 | 96.49 % |
Company contact information
![address Arch Therapeutics, Inc.(ARTH)](https://cdn.zonebourse.com/static/address/120795248.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-86.74% | 4.27M | |
+10.87% | 126B | |
-0.88% | 11.73B | |
-23.89% | 6.62B | |
+50.07% | 6.51B | |
-34.16% | 3.98B | |
+8.50% | 3.44B | |
-20.67% | 2.44B | |
-19.65% | 1.88B | |
-23.49% | 1.69B |
- Stock Market
- Equities
- ARTH Stock
- Company Arch Therapeutics, Inc.